Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention

BMC Pediatrics

Thomas Reinehr¹  Clinton T Elfers³  Ellen A Schur⁴  Anke Hinney²  Christian L Roth³ 

[1] Pediatric Endocrinology, Diabetes, and Nutrition Medicine, Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Dr. F. Steiner Str. 5, Datteln 45711, Germany;Department of Child and Adolescent Psychiatry, Universitätsklinikum Essen (AöR), University of Duisburg-Essen, Wickenburgstr, Essen 21, 45147, Germany;Department of Pediatrics, University of Washington, Seattle Children’s Research Institute, 1900 Ninth Ave, Seattle, WA 98101, USA;Internal Medicine, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195, USA

关键词: Weight reduction;    Lifestyle intervention;    Obesity;    Dopamine receptor polymorphisms;   

Others  :  1144110
DOI  :  10.1186/1471-2431-13-197

 received in 2013-06-10, accepted in 2013-11-22,  发布年份 2013

【 摘 要 】

Background

Dopamine receptors are involved in midbrain reward circuit activation. Polymorphisms in two dopamine receptor genes, DRD2 and DRD4, have been associated with altered perception of food reward and weight gain. The objective of this study was to determine whether the same risk alleles were associated with overweight/obesity and with lower reduction of overweight after a 1-year lifestyle intervention.

Methods

In a longitudinal study the association of polymorphisms in DRD2 (rs18000497, risk allele: T, formerly A1 allele at the TaqI A1 polymorphism) and DRD4 (variable number of tandem repeats (VNTR); 48 bp repeat in exon III; risk alleles: 7 repeats or longer: 7R+) was tested on weight loss success following a 1-year lifestyle childhood obesity intervention (OBELDICKS). An additional exploratory cross-sectional case-control study was performed to compare the same DRD polymorphisms in these overweight/obese children and adolescents versus lean adult controls. Subjects were 423 obese and 28 overweight children participating in lifestyle intervention (203 males), age median 12.0 (interquartile range 10.0–13.7) years, body mass index - standard deviation score (BMI-SDS) 2.4 ± 0.5; 583 lean adults (232 males); age median 25.3 (interquartile range 22.5–26.8) years, BMI 19.1 ± 1.9 kg/m². BMI, BMI-SDS and skinfold thickness measures were assessed at baseline and after 1 year; genotyping was performed for DRD2 risk variant rs1800497 and DRD4 exon III VNTR.

Results

The DRD2 genotype had a nominal effect on success in the weight loss intervention. The weakest BMI-SDS reduction was in children homozygous for two rs1800497 T-alleles (n = 11) compared to the combined group with zero (n = 308) or one (n = 132) rs1800497 T-allele (-0.08 ± 0.36 vs. -0.28 ± 0.34; p < 0.05). There was no association between the DRD4 VNTR alleles and genotypes and success in the weight loss intervention. No associations of the risk alleles of the DRD2 and DRD4 polymorphisms and obesity were observed in the cross-sectional part of the study.

Conclusions

We did not find association between polymorphisms in DRD2 and DRD4 genes and weight status. However, obese carriers of two DRD2 rs1800497 T-alleles may be at risk for weak responses to lifestyle interventions aimed at weight reduction.

Trial registration

Obesity intervention program “Obeldicks” is registered at clinicaltrials.gov (NCT00435734).

【 授权许可】

   
2013 Roth et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Doehring A, Kirchhof A, Lotsch J: Genetic diagnostics of functional variants of the human dopamine D2 receptor gene. Psychiatr Genet 2009, 19(5):259-268.
• [2]Chen D, Liu F, Shang Q, Song X, Miao X, Wang Z: Association between polymorphisms of DRD2 and DRD4 and opioid dependence: evidence from the current studies. Am J Med Genet B Neuropsychiatr Genet 2011, 156B(6):661-670.
• [3]Mignini F, Napolioni V, Codazzo C, Carpi FM, Vitali M, Romeo M, Ceccanti M: DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy. Neurosci Lett 2012, 522(2):103-107.
• [4]Mehta S, Melhorn SJ, Smeraglio A, Tyagi V, Grabowski T, Schwartz MW, Schur EA: Regional brain response to visual food cues is a marker of satiety that predicts food choice. Am J Clin Nutr 2012, 96(5):989-999.
• [5]Nicola SM: The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacol (Berl) 2007, 191(3):521-550.
• [6]Del Parigi A, Gautier JF, Chen K, Salbe AD, Ravussin E, Reiman E, Tataranni PA: Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann N Y Acad Sci 2002, 967:389-397.
• [7]LaBar KS, Gitelman DR, Parrish TB, Kim YH, Nobre AC, Mesulam MM: Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci 2001, 115(2):493-500.
• [8]Uher R, Treasure J, Heining M, Brammer MJ, Campbell IC: Cerebral processing of food-related stimuli: effects of fasting and gender. Behav Brain Res 2006, 169(1):111-119.
• [9]Stice E, Yokum S, Bohon C, Marti N, Smolen A: Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4. Neuroimage 2010, 50(4):1618-1625.
• [10]Comings DE, Blum K: Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000, 126:325-341.
• [11]Wang GJ, Volkow ND, Fowler JS: The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002, 6(5):601-609.
• [12]DelParigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, Tataranni PA: Persistence of abnormal neural responses to a meal in postobese individuals. Int J Obes Relat Metab Disord 2004, 28(3):370-377.
• [13]Stoeckel LE, Kim J, Weller RE, Cox JE, Cook EW 3rd, Horwitz B: Effective connectivity of a reward network in obese women. Brain Res Bull 2009, 79(6):388-395.
• [14]Davis C, Fox J: Sensitivity to reward and body mass index (BMI): evidence for a non-linear relationship. Appetite 2008, 50(1):43-49.
• [15]Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Nagren K, Kaasinen V: Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007, 61(9):748-756.
• [16]Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, et al.: Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008, 42(4):1537-1543.
• [17]Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P: The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 2004, 67(1):75-85.
• [18]Ritchie T, Noble EP: Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 2003, 28(1):73-82.
• [19]Davis C, Levitan RD, Yilmaz Z, Kaplan AS, Carter JC, Kennedy JL: Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuropsychopharmacol Biol Psychiatry 2012, 38(2):328-335.
• [20]Noain D, Avale ME, Wedemeyer C, Calvo D, Peper M, Rubinstein M: Identification of brain neurons expressing the dopamine D4 receptor gene using BAC transgenic mice. Eur J Neurosci 2006, 24(9):2429-2438.
• [21]Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH: Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995, 65(3):1157-1165.
• [22]Stice E, Spoor S, Bohon C, Small DM: Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322(5900):449-452.
• [23]Muller TD, Tschop MH, Jarick I, Ehrlich S, Scherag S, Herpertz-Dahlmann B, Zipfel S, Herzog W, de Zwaan M, Burghardt R, et al.: Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. J Psychiatr Res 2011, 45(5):706-711.
• [24]Kromeyer-Hauschild K, Wabitsch M, Geller F, et al.: Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001, 149:807-818.
• [25]Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA: Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988, 60(5):709-723.
• [26]Reinehr T, de Sousa G, Toschke AM, Andler W: Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr 2006, 84(3):490-496.
• [27]Hinney A, Schneider J, Ziegler A, Lehmkuhl G, Poustka F, Schmidt MH, Mayer H, Siegfried W, Remschmidt H, Hebebrand J: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. Am J Med Genet 1999, 88(6):594-597.
• [28]Lunetta KL: Genetic association studies. Circulation 2008, 118(1):96-101.
• [29]Cole TJ: The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990, 44(1):45-60.
• [30]Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, Monterosso JR, Aron AR, Mandelkern MA, et al.: Striatal dopamine D2/D3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 2012, 32(21):7316-7324.
• [31]Rieger M, Gauggel S, Burmeister K: Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions. Neuropsychology 2003, 17(2):272-282.
• [32]Aron AR, Durston S, Eagle DM, Logan GD, Stinear CM, Stuphorn V: Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci 2007, 27(44):11860-11864.
• [33]Mostofsky SH, Simmonds DJ: Response inhibition and response selection: two sides of the same coin. J Cogn Neurosci 2008, 20(5):751-761.
• [34]Chambers CD, Garavan H, Bellgrove MA: Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 2009, 33(5):631-646.
• [35]Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakrapani S, Lee B, London ED: Different forms of self-control share a neurocognitive substrate. J Neurosci 2011, 31(13):4805-4810.
• [36]Braet C, Claus L, Verbeken S, Van Vlierberghe L: Impulsivity in overweight children. Eur Child Adolesc Psychiatry 2007, 16(8):473-483.
• [37]Nederkoorn C, Jansen E, Mulkens S, Jansen A: Impulsivity predicts treatment outcome in obese children. Behav Res Ther 2007, 45(5):1071-1075.
• [38]van den Berg L, Pieterse K, Malik JA, Luman M, Willems van Dijk K, Oosterlaan J, Delemarre-van de Waal HA: Association between impulsivity, reward responsiveness and body mass index in children. Int J Obes (Lond) 2011, 35(10):1301-1307.
• [39]Guo G, North KE, Gorden-Larsen P, Bulik CM, Choi S: Body mass, DRD4, physical activity, sedentary behavior, and family socioeconomic status: the add health study. Obesity (Silver Spring) 2007, 15(5):1199-1206.
• [40]Kaplan AS, Levitan RD, Yilmaz Z, Davis C, Tharmalingam S, Kennedy JL: A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord 2008, 41(1):22-28.
• [41]Sobik L, Hutchison K, Craighead L: Cue-elicited craving for food: a fresh approach to the study of binge eating. Appetite 2005, 44(3):253-261.
• [42]McClernon FJ, Hutchison KE, Rose JE, Kozink RV: DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacol (Berl) 2007, 194(4):433-441.
• [43]Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE: Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 2008, 32(7):1113-1123.
• [44]Shao C, Li Y, Jiang K, Zhang D, Xu Y, Lin L, Wang Q, Zhao M, Jin L: Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese. Psychopharmacol (Berl) 2006, 186(2):185-190.
• [45]Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC: Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 2001, 55(5):605-611.
• [46]Fang YJ, Thomas GN, Xu ZL, Fang JQ, Critchley JA, Tomlinson B: An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol 2005, 102(1):111-116.
• [47]Chen AL, Blum K, Chen TJ, Giordano J, Downs BW, Han D, Barh D, Braverman ER: Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report. Food Funct 2012, 3(1):40-48.
• [48]Jenkinson CP, Hanson R, Cray K, Wiedrich C, Knowler WC, Bogardus C, Baier L: Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians. Int J Obes Relat Metab Disord 2000, 24(10):1233-1238.
• [49]Southon A, Walder K, Sanigorski AM, Zimmet P, Nicholson GC, Kotowicz MA, Collier G: The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab 2003, 16(1):72-76.
• [50]Fuemmeler BF, Agurs-Collins TD, McClernon FJ, Kollins SH, Kail ME, Bergen AW, Ashley-Koch AE: Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008, 16(2):348-355.
• [51]Snijder MB, Visser M, Dekker JM, Seidell JC, Fuerst T, Tylavsky F, Cauley J, Lang T, Nevitt M, Harris TB: The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 2002, 26(7):984-993.
• [52]Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH: Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997, 337(13):869-873.
• [53]Esposito-Smythers C, Spirito A, Rizzo C, McGeary JE, Knopik VS: Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav 2009, 93(3):306-312.